CAMBRIDGE, Mass.–(BUSINESS WIRE)– Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
focused on the development and commercialization of therapeutics for
patients with kidney disease, today announced that its President and
Chief Executive Officer, John P. Butler, will present at the 37th
Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019
at 9:30 a.m. Pacific Time at the Westin St. Francis in San Francisco.
A live webcast of the presentation will be available on the company’s
website at www.akebia.com.
To access, please log onto the Akebia website at least 15 minutes prior
to the webcast to ensure adequate time for any software downloads that
may be required. A replay of the webcast will be available on Akebia’s
website following the conference.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical
company focused on the development and commercialization of therapeutics
for patients with kidney disease. The company was founded in 2007 and is
headquartered in Cambridge, Massachusetts. For more information, please
visit our website at www.akebia.com,
which does not form a part of this release.
Akebia Therapeutics Contact:
Forst / Maghan Meyers
Source: Akebia Therapeutics, Inc.